Mark Donohue | Vice President of Investor Relations and Corporate Communications |
Rob Stewart | President and Chief Executive Officer |
Todd Branning | Chief Financial Officer |
Joe Todisco | Senior Vice President of Specialty Commercial |
Jennifer Kim | Cantor Fitzgerald |
Gary Nachman | BMO Capital Markets |
David Amsellem | Piper Jaffray |
Eason Lee | SVB Leerink |
Greg Fraser | SunTrust |
Dewey Steadman | Canaccord |
Dan Busby | RBC Capital |
Tim Chiang | BTIG |
Good morning, and welcome to the Amneal Pharmaceuticals First Quarter 2019 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. At this time, I would like to turn the conference over to Mark Donohue, Vice President of Investor Relations and Communications.